HotSpot Therapeutics Appoints Alison O’Neill, M.D., as Chief Medical Officer
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting regulatory sites on proteins referred to as “natural hotspots,” today announced the appointment of Alison O’Neill, M.D., as Chief Medical Officer. https://mma.prnewswire.com/media/1914271/HotSpot_Therapeutics_Logo.jpg “I am thrilled to welcome Alison, an accomplished industry leader, to HotSpot,” said Jonathan Montagu, […]